Erding Hu

12.6k total citations · 3 hit papers
48 papers, 9.9k citations indexed

About

Erding Hu is a scholar working on Molecular Biology, Physiology and Genetics. According to data from OpenAlex, Erding Hu has authored 48 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 13 papers in Physiology and 7 papers in Genetics. Recurrent topics in Erding Hu's work include Adipose Tissue and Metabolism (11 papers), Peroxisome Proliferator-Activated Receptors (9 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Erding Hu is often cited by papers focused on Adipose Tissue and Metabolism (11 papers), Peroxisome Proliferator-Activated Receptors (9 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Erding Hu collaborates with scholars based in United States, Canada and Taiwan. Erding Hu's co-authors include Bruce M. Spiegelman, Peter Tontonoz, Peng Liang, Jae Bum Kim, Pasha Sarraf, C S Rubin, Jerry H. Devine, Elmus Beale, Zunxuan Chen and Regina P. Brun and has published in prestigious journals such as Science, Cell and Nucleic Acids Research.

In The Last Decade

Erding Hu

47 papers receiving 9.7k citations

Hit Papers

Stimulation of adipogenesis in fibroblasts by PPARγ2, a l... 1994 2026 2004 2015 1994 1996 1996 1000 2.0k 3.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erding Hu United States 31 6.4k 3.9k 3.0k 1.1k 846 48 9.9k
Naoto Kubota Japan 57 5.6k 0.9× 3.1k 0.8× 2.9k 1.0× 859 0.8× 987 1.2× 155 11.0k
Liliane Michalik Switzerland 47 6.4k 1.0× 2.4k 0.6× 1.3k 0.4× 1.6k 1.4× 595 0.7× 86 9.2k
Y. Le Marchand‐Brustel France 59 7.6k 1.2× 3.5k 0.9× 2.7k 0.9× 1.3k 1.2× 1.2k 1.4× 156 13.0k
Satoshi Yamashita Japan 39 4.1k 0.6× 1.9k 0.5× 2.4k 0.8× 1.0k 0.9× 946 1.1× 175 8.2k
Yasutomi Kamei Japan 45 6.2k 1.0× 2.9k 0.7× 1.6k 0.5× 755 0.7× 852 1.0× 104 10.4k
Guillaume Adelmant United States 31 6.8k 1.1× 4.4k 1.1× 1.5k 0.5× 927 0.8× 673 0.8× 54 9.6k
Marc Liesa United States 44 6.5k 1.0× 2.8k 0.7× 2.2k 0.7× 1.0k 0.9× 560 0.7× 83 9.4k
Hei Sook Sul United States 60 7.3k 1.1× 6.1k 1.6× 4.1k 1.4× 1.5k 1.3× 642 0.8× 124 14.4k
Jean‐François Tanti France 46 6.2k 1.0× 2.3k 0.6× 1.9k 0.6× 1.5k 1.3× 1.3k 1.5× 115 9.3k
Jennifer Rieusset France 52 5.9k 0.9× 3.0k 0.8× 1.9k 0.6× 1.1k 1.0× 302 0.4× 117 9.0k

Countries citing papers authored by Erding Hu

Since Specialization
Citations

This map shows the geographic impact of Erding Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erding Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erding Hu more than expected).

Fields of papers citing papers by Erding Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erding Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erding Hu. The network helps show where Erding Hu may publish in the future.

Co-authorship network of co-authors of Erding Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Erding Hu. A scholar is included among the top collaborators of Erding Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erding Hu. Erding Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abedini, Amin, Mustafa Al‐Obaidi, Kishor Devalaraja‐Narashimha, et al.. (2022). An Interim Analysis of Clinical and Histopathological Results of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study. Journal of the American Society of Nephrology. 33(11S). 119–119. 1 indexed citations
2.
Kuan, Chia-Yi, Hong‐Ru Chen, Ning Gao, et al.. (2020). Brain-targeted hypoxia-inducible factor stabilization reduces neonatal hypoxic-ischemic brain injury. Neurobiology of Disease. 148. 105200–105200. 13 indexed citations
3.
Frazier, Kendall S., et al.. (2019). Carcinogenicity Assessment of Daprodustat (GSK1278863), a Hypoxia-Inducible Factor (HIF)-Prolyl Hydroxylase Inhibitor. Toxicologic Pathology. 48(2). 362–378. 20 indexed citations
4.
Zhou, Jin, Jie Li, Daniel M. Rosenbaum, et al.. (2017). The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits. PLoS ONE. 12(9). e0184049–e0184049. 30 indexed citations
5.
Zhao, Huizhen, Yong Jiang, Sharon Sweitzer, et al.. (2014). Crystallographic Structure of a Small Molecule SIRT1 Activator/Enzyme Complex. Biophysical Journal. 106(2). 646a–646a. 6 indexed citations
6.
Xu, Huansheng, B. Alexander Yi, Hao Wu, et al.. (2011). Highly efficient derivation of ventricular cardiomyocytes from induced pluripotent stem cells with a distinct epigenetic signature. Cell Research. 22(1). 142–154. 61 indexed citations
7.
Johns, Douglas G., Dorothy Zelent, Zhaohui Ao, et al.. (2009). Heme-oxygenase induction inhibits arteriolar thrombosis in vivo: Effect of the non-substrate inducer cobalt protoporphyrin. European Journal of Pharmacology. 606(1-3). 109–114. 11 indexed citations
8.
Khandekar, Sanjay, Tracey Yi, Susan Chen, et al.. (2006). Expression, Purification, and Characterization of an Enzymatically Active Truncated Human Rho-Kinase I (ROCK I) Domain Expressed in Sf-9 Insect Cells. Protein and Peptide Letters. 13(4). 369–376. 4 indexed citations
9.
Hu, Erding. (2006). Recent Patents on Rho Signaling Pathway as Therapeutic Target for Cardiovascular Diseases. Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery). 1(3). 249–263. 7 indexed citations
10.
Hu, Erding, Edward Dul, Chiu-Mei Sung, et al.. (2003). Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases. Journal of Pharmacology and Experimental Therapeutics. 307(2). 720–728. 300 indexed citations
11.
Chen, Zunxuan, et al.. (2003). Expression and functional role of Rho‐kinase in rat urinary bladder smooth muscle. British Journal of Pharmacology. 138(5). 757–766. 132 indexed citations
12.
Hu, Erding & Bruce M. Spiegelman. (2003). Identification of Novel Genes Involved in Adipose Differentiation by Differential Display. Humana Press eBooks. 85. 195–204. 1 indexed citations
14.
Hu, Erding, Zunxuan Chen, Todd A. Fredrickson, et al.. (2001). Rapid Isolation of Tissue-Specific Genes from Rat Kidney. Nephron Experimental Nephrology. 9(2). 156–164. 5 indexed citations
15.
King, Frederick J., et al.. (1999). DEF-1, a Novel Src SH3 Binding Protein That Promotes Adipogenesis in Fibroblastic Cell Lines. Molecular and Cellular Biology. 19(3). 2330–2337. 37 indexed citations
16.
Hu, Erding, Yuan Zhu, Todd A. Fredrickson, et al.. (1998). Tissue Restricted Expression of Two Human Frzbs in Preadipocytes and Pancreas. Biochemical and Biophysical Research Communications. 247(2). 287–293. 37 indexed citations
17.
Brun, Regina P., Jae Bum Kim, Erding Hu, Soner Altiok, & Bruce M. Spiegelman. (1996). Adipocyte differentiation: a transcriptional regulatory cascade. Current Opinion in Cell Biology. 8(6). 826–832. 150 indexed citations
18.
Zhang, Bing, J Berger, Erding Hu, et al.. (1996). Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha.. Molecular Endocrinology. 10(11). 1457–1466. 276 indexed citations
19.
Tontonoz, Peter, Erding Hu, & Bruce M. Spiegelman. (1995). Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor γ. Current Opinion in Genetics & Development. 5(5). 571–576. 401 indexed citations
20.
Tontonoz, Peter, Reed A. Graves, Adriane I. Budavari, et al.. (1994). Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR7 and RXRa. Nucleic Acids Research. 22(25). 5628–5634. 334 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026